通过调整c-Kit信号来解干细胞因子的功能变性
Chia Chi M Ho1, Akanksha Chhabra2, Philipp Starkl3
1Department of Bioengineering, Stanford University School of Engineering, 443 Via Ortega, Stanford, CA 94305, USA; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA.
设计了一种干细胞因子 (SCF) 部分激动剂,以选择性地激活造血细胞的祖先. 这种治疗方法尽量减少过敏反应,同时保持造血扩张的有效性.
科学领域:
- 生物化学
- 分子生物学
- 免疫学
背景情况:
- 由于受体的广泛表达,生长因子和细胞因子往往表现出性,从而限制了它们的治疗潜力.
- 干细胞因子 (SCF) 通过c-Kit刺激造血原体扩张,但可以通过激活巨细胞引起毒性.
- 在开发有效和安全的细胞因子疗法方面,性疗法构成了重大挑战.
研究的目的:
- 设计一种基于机制的SCF部分激动剂,可选择性地向造血原体.
- 减少与SCF治疗相关的过敏性副作用.
- 在临床前模型中证明偏向性SCF激动剂的治疗效果.
主要方法:
- 设计了一个SCF变体来损害c-Kit受体二元化,从而调节下游信号.
- 在实验室和体内评估了血造细胞原始细胞与巨细胞的偏差激活.
- 在过敏反应,放射保护和造血扩张的小鼠模型中评估了SCF部分激动剂的疗效和安全性.
主要成果:
- 改造的SCF部分激动剂显示出血造细胞的偏向激活在巨细胞上.
- 在体内研究显示血液形成扩张和辐射保护的疗效保持.
- 与野生型SCF相比,SCF部分激动剂显著减少了过敏性脱效应.
结论:
- 部分激动剂的基于机制的工程可以克服生长因子和细胞因子的变性限制.
- 调整受体二分化和信号值为开发更安全,更有效的治疗方法提供了策略.
- 这种方法对药物开发中的其他二维受体-连接体系统具有广泛的适用性.
更多相关视频
07:18A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
相关概念视频
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Lineage Commitment
Somatic to iPS Cell Reprogramming
Stem Cell Niche
